.png)
glp 1 drugs thyroid cancer Does Using GLP-1 Drugs, Like Zepbound or Wegovy, Increase Your Risk of Cancer? Do GLP-1 Agonists Cause Thyroid
Description
Glucagon-like peptide1 receptor agonists (GLP-1RAs) have emerged as a transformative class of therapies initially developed for glycemic control in type2 diabetes mellitus
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
Persistent cravings for sweets, processed foods, and high-calorie snacks
Who it's for
The formula acts as a natural appetite suppressant, supports metabolism, balances hunger, and promotes energy
An obesity medicine specialist explains why thats not a good idea.
